Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00593840 · ClinicalTrials.gov registry record · Phase 2
Phase II Trial Evaluating Elimination of Radiation Therapy
A Phase 2 study of Cancer of the Larynx, sponsored by Washington University School of Medicine.
- Active
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT00593840 is a Phase 2 study of Cancer of the Larynx that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 74 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00593840, a Phase 2 study of Cancer of the Larynx, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if reducing or eliminating radiation treatment to one or both sides of the neck where there is no evidence of cancer can help spare the side effects of radiation treatment for head and neck cancer. In this study, the investigators plan to reduce the amount of radiation treatment received to healthy tissue
Conditions Studied
Interventions
- RADIATION Intensity modulated radiation therapy
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2007-04-11 |
| Est. Completion | 2026-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00593840
The ClinicalTrials.gov registry entry for NCT00593840 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer of the Larynx appearing as the primary indexed condition, and to 1 intervention - of which Intensity modulated radiation therapy is the first listed.
NCT00593840 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT00593840 about?
NCT00593840 is a clinical study titled "Phase II Trial Evaluating Elimination of Radiation Therapy". The purpose of this study is to determine if reducing or eliminating radiation treatment to one or both sides of the neck where there is no evidence of cancer can help spare the side effects of radiation treatment for head and neck cancer. In this study, the investigators plan to reduce the amount o...
What is the current status of trial NCT00593840?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2007-04-11. Estimated completion is 2026-04-30.
What conditions does trial NCT00593840 study?
This clinical trial studies the following conditions: Cancer of the Larynx.
What interventions are being tested in trial NCT00593840?
The interventions under investigation include: Intensity modulated radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00593840?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00593840 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer of the Larynx
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.